These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18398103)

  • 1. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Chu DZ
    J Natl Cancer Inst; 2008 Apr; 100(8):596-7. PubMed ID: 18398103
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Byers T; Trujillo S; Hines L
    J Natl Cancer Inst; 2008 Apr; 100(8):596. PubMed ID: 18398102
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Caan B; Habel L; Quesenberry C; Kushi L; Herrinton L
    J Natl Cancer Inst; 2008 Apr; 100(8):597-8; author reply 599. PubMed ID: 18398101
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Vaidya JS
    J Natl Cancer Inst; 2008 Apr; 100(8):598-9; author reply 599. PubMed ID: 18398100
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Ponti A; Rosso S; Zanetti R; Ricceri F; Tomatis M; Segnan N
    J Natl Cancer Inst; 2007 Dec; 99(23):1817-8; author reply 1819. PubMed ID: 18042935
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Anderson BO
    J Natl Cancer Inst; 2007 Dec; 99(23):1815-6; author reply 1816-7. PubMed ID: 18042937
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast cancer cases decline; may be tied to drop in hormone use.
    Mayo Clin Womens Healthsource; 2007 May; 11(5):3. PubMed ID: 17476172
    [No Abstract]   [Full Text] [Related]  

  • 9. Mammographic density, response to hormones, and breast cancer risk.
    Boyd NF; Melnichouk O; Martin LJ; Hislop G; Chiarelli AM; Yaffe MJ; Minkin S
    J Clin Oncol; 2011 Aug; 29(22):2985-92. PubMed ID: 21709206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.
    Li CI; Chlebowski RT; Freiberg M; Johnson KC; Kuller L; Lane D; Lessin L; O'Sullivan MJ; Wactawski-Wende J; Yasmeen S; Prentice R
    J Natl Cancer Inst; 2010 Sep; 102(18):1422-31. PubMed ID: 20733117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Press statement. Breast cancer and hormone therapy: a looking-glass mirror?
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2007 Oct; 10(5):356-7. PubMed ID: 17852137
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Robbins AS; Clarke CA
    J Natl Cancer Inst; 2007 Dec; 99(23):1815; author reply 1816-7. PubMed ID: 18042938
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women.
    Yoshimoto N; Nishiyama T; Toyama T; Takahashi S; Shiraki N; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
    Cancer Sci; 2011 Nov; 102(11):2065-72. PubMed ID: 21790896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
    Simon JA; Nahum GG; Stanislaw H; Gaines T
    Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer incidence and hormone replacement therapy in Canada.
    De P; Neutel CI; Olivotto I; Morrison H
    J Natl Cancer Inst; 2010 Oct; 102(19):1489-95. PubMed ID: 20864685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Million Women Study and breast cancer.
    Speroff L
    Maturitas; 2003 Sep; 46(1):1-6. PubMed ID: 12963165
    [No Abstract]   [Full Text] [Related]  

  • 17. Narrowing of racial disparities in breast cancer incidence: insights from menopausal hormone therapy study findings.
    Anderson GL; Barrington WE
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26613938
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between selenium intake and breast cancer risk: results from the Women's Health Initiative.
    Guo D; Hendryx M; Liang X; Manson JE; He K; Vitolins MZ; Li Y; Luo J
    Breast Cancer Res Treat; 2020 Aug; 183(1):217-226. PubMed ID: 32607639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is estrogen therapy of significance for the incidence of breast cancer?].
    Bakken K
    Tidsskr Nor Laegeforen; 2004 Nov; 124(21):2801; author reply 2801. PubMed ID: 15534689
    [No Abstract]   [Full Text] [Related]  

  • 20. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.